有前途的细胞因子辅助剂可增强结核病疫苗免疫力
Xuezhi Cao1,2, Yang-Xin Fu3, Hua Peng1,2
1State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510182, China.
新的结核疫苗可能很快成为现实. 研究人员正在探索细胞因子,如干扰素和介质蛋白,作为辅助剂,以提高针对Mycobacterium tuberculosis的疫苗有效性.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 传染性疾病 传染性疾病
背景情况:
- 由Mycobacterium tuberculosis引起的结核病 (TB) 是一个主要的全球健康问题.
- 目前的细菌卡尔梅特-盖林 (BCG) 疫苗对成人肺结核提供有限的保护.
- 迫切需要新的疫苗接种策略来打击结核病.
研究的目的:
- 审查细胞因子作为结核病疫苗辅助剂的潜力.
- 突出特定的细胞因子,可以增强疫苗诱导的免疫反应对M.结核病.
主要方法:
- 关于细胞因子和结核病疫苗辅助剂的研究文献综述.
- 分析细胞因子在调节与M.结核病感染相关的免疫反应中的作用.
主要成果:
- 一些细胞因子,包括I型和II型干扰素 (IFN) 和白细胞间蛋白 (IL-2,IL-7,IL-15,IL-12,IL-21) 作为疫苗辅助剂具有前景.
- 在结核病模型中,花细胞-巨细胞殖民地刺激因子 (GM-CSF) 已在增强免疫反应方面表现出有效性.
结论:
- 作为辅助剂的细胞因子的战略性使用可以显著提高结核病疫苗的疗效.
- 细胞因子辅助剂有望开发针对Mycobacterium tuberculosis的更有效的疫苗.
- 对细胞因子辅助结核病疫苗的进一步研究是有必要的.
更多相关视频
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
10:11Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System
Published on: January 31, 2018
相关概念视频
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Vaccinations
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
